Jaka jest cena za Roche Holding AG (RO)

Cena za Roche Holding AG (RO) wynosi $481.73

Jaka jest kapitalizacja rynkowa dla Roche Holding AG (RO)

Kapitalizacja rynkowa dla Roche Holding AG (RO) wynosi $377.65B

Zyski Roche Holding AG (RO)

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Rok	Zyski	Zmień
Za mało danych dla podanych dat.

Rok

Zyski

Zmień

Za mało danych dla podanych dat.

Firma	Zyski	Różnica w zyskach	Kraj
Eli Lilly and Company LLY.US	$33.59B	57.07%	US
Johnson & Johnson JNJ.US	$25.20B	17.80%	US
AbbVie Inc. ABBV.US	$8.70B	-59.33%	US
Merck & Co., Inc. MRK.US	$5.95B	-72.19%	US
Novartis AG NOVN.SW	$16.38B	-23.42%	CH

Firma

Zyski

Różnica w zyskach

Kraj